One Aerin™ Console, Two Styluses:
Our proprietary, temperature-controlled radiofrequency (RF) technology is optimized for the nasal airway. Unlike traditional RF, the Aerin™ System automatically adjusts the power output to maintain target temperature for therapeutic benefit while sparing surrounding tissue, including mucosa.
Heats From Within While Sparing Surface Tissue5
Precise Treatment Zone5
VivAer and RhinAer fit seamlessly into the office or OR environment. Many payers have coverage policies in place for the treatment of nasal airway obstruction or chronic rhinitis. To learn more, contact Aerin Medical at (833)-484-8237
1 VivAer Stylus. Prospective, Non-randomized, Multi-Center Clinical Study. 39 Patients. Patient reported NOSE score and QOL survey. Endpoint from baseline to 24 months. Aerin Medical TR680-01.
2 RhinAer Stylus. Prospective, Non-randomized, Multi-Center Clinical Study. 50 patients. Endpoint from baseline to 52 weeks, Patient reported rTNSS score. Aerin Medical TR898.
3 VivAer Stylus. Prospective, Multi-Center, Non-Randomized Clinical Study. 50 patients. Endpoint from baseline to 12 weeks. Patient reported NOSE score. Aerin Medical TR470.
4 Bailey LeConte, MD, Garren M.I. Low, MD, Martin J. Citardi, MD, William C. Yao, MD, Arturo A. Eguia, MD, and Amber U. Luong, MD, PhD, International Forum of Allergy & Rhinology 2020 and included references. https://doi.org/10.1002/alr.22679. McGovern Medical School at the University of Texas Health Science Center, Houston TX.
5 Data on file. Aerin Medical MKT691.